A5068898929- Sarcoma Diagnosis and Treatment
- Melanoma and MAPK Pathways
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Treatments and Studies
- Beetle Biology and Toxicology Studies
- Renal and related cancers
- Cancer Genomics and Diagnostics
- HER2/EGFR in Cancer Research
- Tumors and Oncological Cases
- Testicular diseases and treatments
- Multiple Myeloma Research and Treatments
- PI3K/AKT/mTOR signaling in cancer
- Uterine Myomas and Treatments
Metaplastic breast carcinomas are rare and carry poor prognoses. They also more aggressive than other cancers known for their resistance to chemotherapy. Prolonged treatment with dabrafenib trametinib is a therapy malignant melanoma that improves the progression-free survival overall survival. Such molecular-targeted therapies being developed BRAF mutation, driver of melanoma. Case Presentation. A 57-year-old woman metaplastic cancer chemotherapy-refractory massive pleural effusion. After...
e14532 Background: In April 2017, MASTER KEY Project, composed of a prospective registry study part and multiple clinical trials part, was established to promote treatment development for rare cancers, which is lacking standard or investigational therapeutic options. Circulating tumor DNA (ctDNA) analysis by next-generation sequencing (NGS) has provided new insight into personalized medicine in more accessible, non-invasive manner; however, most reports are focused on common cancers. We...